Compare Novavax Inc (NVAX) vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock (TTWO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock — how do they compare? Novavax Inc trades at $9.85 (market cap $1.62B), while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock trades at $210.97 (market cap $39.48B). The key difference: TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock is far larger — about 24.4× Novavax Inc's market cap, and Novavax Inc is trading nearer its 52-week high, TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock nearer its low. Which is the better fit depends on your goals.
| NVAX | TTWO | |
|---|---|---|
Market Cap | $1.62B | $39.48B |
Sector | Health | Media |
52-Week High | $11.19 | $262.29 |
52-Week Low | $6.22 | $189.69 |
Enterprise Value | $1.20B | $40.60B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novavax (NVAX) trades at $10.19, down 0.29% today, with a bullish technical signal from moving averages but overbought RSI levels. Recent Q2 2026 earnings beat expectations, and the company raised its 2026 revenue outlook. Key developments include regulatory approvals for its updated COVID-19 vaccine in the U.S., EU, and Japan for the 2026-2027 season, alongside ongoing partnerships with Sanofi and Pfizer.
The outlook is mixed: strong analyst buy ratings (73.9%) and partnership milestones offer upside, but negative net income margins and cash flow challenges pose risks. Investors should weigh the potential from vaccine demand and adjuvant platform royalties against financial sustainability concerns and competitive pressures in the biotech sector.
Take-Two Interactive (TTWO) trades at $213.29, down 0.65% on the day, amid bearish technical signals but strong analyst optimism driven by the upcoming Grand Theft Auto VI launch. The stock shows negative profitability with a net income margin of -4.79% and elevated valuation ratios, yet revenue growth to $5.63 billion in 2025 and recent earnings beats highlight operational resilience. Cash flow trends are volatile, with 2025 net cash flow positive at $457 million due to financing activities, while debt-to-asset ratio rose to 39.87%.
The outlook hinges on GTA VI's success, with a consensus price target of $302.60 implying significant upside. Risks include execution missteps, competitive pressures, and high debt, but institutional buying and no sell ratings reflect confidence in the long-term franchise value. Near-term volatility is expected around product launches and market sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock
Found in 1993, Take-Two consists of three wholly owned labels, Rockstar Games, 2K, and Zynga. The firm is one of the world's largest independent video game publishers on consoles, PCs, smartphones, and tablets. Take-Two's franchise portfolio is headlined by Grand Theft Auto (345 million units sold) and contains other well-known titles such as NBA 2K, Civilization, Borderlands, Bioshock, and Xcom. Zynga mobile titles include Farmville, Empires & Puzzles, and CSR Racing.
Read more on TTWO →
